Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30050147HIVENSG00000011566.15protein_codingMAP4K3NoNo8491Q8IVH8
TVIS30050148HIVENSG00000011566.15protein_codingMAP4K3NoNo8491Q8IVH8
TVIS30050149HIVENSG00000011566.15protein_codingMAP4K3NoNo8491Q8IVH8
TVIS30050150HIVENSG00000011566.15protein_codingMAP4K3NoNo8491Q8IVH8
TVIS20009485HPVENSG00000011566.15protein_codingMAP4K3NoNo8491Q8IVH8
TVIS20032826HPVENSG00000011566.15protein_codingMAP4K3NoNo8491Q8IVH8
TVIS20029453HPVENSG00000011566.15protein_codingMAP4K3NoNo8491Q8IVH8
TVIS20067321HPVENSG00000011566.15protein_codingMAP4K3NoNo8491Q8IVH8
TVIS20065081HPVENSG00000011566.15protein_codingMAP4K3NoNo8491Q8IVH8
TVIS44024800HTLV-1ENSG00000011566.15protein_codingMAP4K3NoNo8491Q8IVH8
TCGA Plot Options
Drug Information
GeneMAP4K3
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0009472
UniProt IDQ8IVH8
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830